Translate
About
Neurizon Therapeutics Limited (AU:NUZ) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2026
Placement of Entitlement Offer Shortfall
Apr 1 2026
NUZ-001 Data Shows Multi-Pathway Protein Clearance
Mar 16 2026
Neurizon announces leadership transition
Feb 26 2026
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
Feb 26 2026
Neurizon Initiates Dosing in HEALEY ALS Platform Trial
Financials
Revenue
A$5.98 M
Market Cap
A$57.42 M
EPS
-0.03